Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on April 30, 2025
Statement of total voting rights and shares forming the company’s share capital as of April 11, 2025
GlobeNewswire
·
April 30, 2025
Article R. 22-10-23 of the French Commercial Code Market: Euronext Paris ISIN code / Mnemo: FR0013233012 / IVA Web site: www.inventivapharma.com Date Number of shares outstanding Total voting rights, gross (1) Total voting rights, net (2) April 11, 2025 95 …
Combined General Meeting of May 22, 2025 - Availability of the preparatory documents
GlobeNewswire
·
April 30, 2025
Daix (France), New York City (New York, United States), April 30, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic …
DBV Technologies Reports First Quarter 2025 Financial Results
GlobeNewswire
·
April 30, 2025
Châtillon, France, April 30, 2025 DBV Technologies Reports First Quarter 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today …
DBV Technologies publie ses résultats financiers du 1er trimestre 2025
GlobeNewswire
·
April 30, 2025
Châtillon, France, le 30 avril (22 :00 CEST) 2025 DBV Technologies publie ses résultats financiers du 1er trimestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP :23306J309), société biopharmaceutique au …
Cytokinetics to Participate in May Investor Conferences
GlobeNewswire
·
April 30, 2025
SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the Company is scheduled to participate in the following investor conferences in May: The Citizens Life Sciences Conference: …
CD8 Technology Signs Letter of Intent for Tevogen Bio’s In-House Manufacturing Facility, Marking First Phase of Up to $50 Million Commitment
GlobeNewswire
·
April 30, 2025
WARREN, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that CD8 Technology Services LLC (“CD8”) has signed a letter of intent for a facility designed to support Tevogen Bio’s cell …
FSR Celebrates Congressional Recognition of April as Sarcoidosis Awareness Month
GlobeNewswire
·
April 30, 2025
CHICAGO, April 30, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) today celebrated the official recognition of April as Sarcoidosis Awareness Month in the U.S. House of Representatives, a meaningful milestone that coincides with the …
UCSF Rosenman RISE Program Welcomes the 2025 Class of Health Innovators
EIN Presswire
·
April 30, 2025
Supporting bold ideas in healthcare through mentorship, community, and commitment to turning bold ideas into life-changing realities. SAN FRANCISCO, CA, UNITED STATES, April 30, 2025 /EINPresswire.com/ -- The UCSF Rosenman RISE Program—one of several …
GenesWell BCT 可以对Oncotype DX 低风险乳腺癌患者进行再分类
EIN Presswire
·
April 30, 2025
SEOUL, SOUTH KOREA, April 30, 2025 /EINPresswire.com/ -- GENCURIX 宣布一项多中心研究结果，评估其乳腺癌预后检测产品 GenesWell BCT 与广泛使用的 21 基因表达检测 Oncotype DX 在预后评估能力方面的表现。 这项回顾性研究纳入了来自韩国五家医疗机构的 759 名早期激素受体阳性、HER2阴性（HR+/HER2- …
GenesWell BCT、Oncotype DXで低リスクと分類された患者の一部を再分類できる
EIN Presswire
·
April 30, 2025
SEOUL, SOUTH KOREA, April 30, 2025 /EINPresswire.com/ -- ジェンキュリックス（GENCURIX）は、同社の乳がん予後検査「GenesWell BCT」と、広く使用されている 「Oncotype DX」(21遺伝子発現検査)の予後リスク分類性能を比較した多施設共同研究の結果を発表しました。 この後ろ向き研究には、韓国の5 …
Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule
GlobeNewswire
·
April 30, 2025
PALO ALTO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the …
Bee Choo Origin Celebrates Over Two Decades of Pioneering Natural Herbal Hair Care Solutions in Southeast Asia
EIN Presswire
·
April 30, 2025
KUALA LUMPURS, MALAYSIA, April 30, 2025 /EINPresswire.com/ -- Bee Choo Origin, a trailblazer in natural herbal-based hair and scalp care, marks more than 20 years of delivering trusted solutions for hair loss and scalp health. Established as one of …
FDA Approves Johnson & Johnson’s IMAAVYTM (nipocalimab-aahu) a New Treatment for Myasthenia Gravis (MG), Offering Hope for Families
GlobeNewswire
·
April 30, 2025
New York, April 30, 2025 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) applauds the U.S. Food and Drug Administration (FDA) approval of IMAAVYTM (nipocalimab-aahu) for the treatment of people ages 12 and older who are living with antibody …
Specialists Eye Gazyva as a New Option for Lupus Nephritis, but ACR Guidelines Favor Benlysta and Lupkynis for Upfront Use, According to Spherix Global Insights
GlobeNewswire
·
April 30, 2025
EXTON, PA, April 30, 2025 (GLOBE NEWSWIRE) -- The American College of Rheumatology’s (ACR) newly updated treatment guidelines for lupus nephritis (LN) have led specialists to reconsider their treatment approaches, particularly around the use of triple …
Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight
GlobeNewswire
·
April 30, 2025
New York, USA, April 30, 2025 (GLOBE NEWSWIRE) -- Metastatic HR+/HER2- Breast Cancer Market—The Road Ahead for Targeted Therapies and Personalized Medicine | DelveInsight In recent years, the treatment landscape of HR+/HER2−ve breast cancer has completely …
Press Release: Annual General Meeting of April 30, 2025
GlobeNewswire
·
April 30, 2025
Annual General Meeting of April 30, 2025 Approval of the financial statements for the fiscal year 2024 Distribution of a cash dividend of €3.92 per share, with payment as of May 14, 2025 Board composition: renewal of four Directors and ratification of the …
Communiqué de presse : Assemblée Générale Annuelle du 30 avril 2025
GlobeNewswire
·
April 30, 2025
Assemblée Générale Annuelle du 30 avril 2025 Approbation des comptes sociaux et des comptes consolidés de l’exercice 2024 Distribution d’un dividende en numéraire de 3,92 euros par action, dont la mise en paiement interviendra le 14 mai 2025 Composition du …
Specialists Set Sights on CLE Pipeline as Unmet Needs Persist and Candidate Pool Expands, According to Spherix Global Insights
GlobeNewswire
·
April 30, 2025
EXTON, PA, April 30, 2025 (GLOBE NEWSWIRE) -- As treatment approaches for cutaneous lupus erythematosus (CLE) continue to evolve, new data from Spherix Global Insights shed light on how specialists are currently managing the condition—and where emerging …
Best Probiotics for Bloating and Gas 2025: Top Probiotic Gut Health Supplements from YourBiology
GlobeNewswire
·
April 30, 2025
GLASGOW, United Kingdom, April 30, 2025 (GLOBE NEWSWIRE) -- YourBiology Gut+ is the best probiotic for bloating, gas, and constipation—powered by Lactobacillus, Bifidobacterium, prebiotics, enzymes, and Vitamin D3 to improve gut health, digestion, and …
ONWARD Medical Convocation of the 2025 Annual General Meeting of Shareholders and Proposed Resolutions
GlobeNewswire
·
April 30, 2025
EINDHOVEN, the Netherlands, April 30, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX ONWRY), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in …